Form 4 Filing: Daly James M Acquires 151 Shares of Cytokinetics Inc. Common Stock

This SEC filing details a transaction by Daly James M, a director at Cytokinetics Inc., on July 15, 2026. Mr. Daly acquired 151 shares of the company's common stock under the Cytokinetics Equity in lieu of Cash Retainer Program. These shares are fully vested at the time of grant. The acquisition price was $82.62 per share, resulting in a post-transaction ownership of 3390 shares. The transaction code is 'A', indicating an acquisition. This filing is Form 4, signed by an attorney-in-fact for Mr. Daly on July 16, 2026.